Paradigm Shift: Reducing Dependence on Serum Creatinine in Acute Kidney Injury
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, October 22, 2009
First Floor Lecture Hall, Forchheimer/Einstein
Cherkasky Auditorium, Moses/Montefiore
Chirag Parikh, MD
Associate Professor of Medicine, Section of Nephrology
Yale University School of Medicine
Associate Professor, Clinical Epidemiology Research Center
VA Connecticut Health Care System
Dr. Chirag Parikh conducts an active patient-oriented research program investigating translational and epidemiological aspects of Acute Kidney Injury (AKI) and other kidney related disorders. His major research interest is developing novel biomarkers of AKI. He is the PI of the NIH sponsored TRIBE-AKI consortium that is conducting two large studies for validating novel urinary biomarkers in AKI. He has authored more than 75 peer-reviewed papers, 10 book chapters, and has given more than 25 invited lectures at scientific meetings and academic institutions around the world.
Dr. Parikh is board certified in Internal Medicine and Nephrology. He has received several awards, such as National Junior Physician Investigator Award from the American Federation of Medical Research, and the “Outstanding Investigator” award at the Western Regional meeting of American Federation of Medical Research (AFMR).
Dr. Parikh received his MD degree from Mumbai, India, in 1996. His post-graduate training involves a residency in Internal Medicine at Nassau University and SUNY at Stony Brook, NY, and a Fellowship in Nephrology and Hypertension at the University of Colorado Health Sciences Center, Denver, CO. He has also completed a PhD in Clinical Investigation and Translational Research at University of Colorado Health Sciences Center, Denver, CO, 2003.
This grand rounds is hosted by the Division of Nephrology.
After attending this activity, participants will be able to:
- Highlight limitations of serum creatinine
- Describe novel kidney injury biomarkers currently in development
- Discuss concepts related to biomarker development
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.